Costs associated with management of non-communicable diseases in the Arab Region: A scoping review

dc.contributor.authorSaleh, Shadi S.
dc.contributor.authorEl-Harakeh, Amena
dc.contributor.authorBaroud, Maysa
dc.contributor.authorZeineddine, Najah
dc.contributor.authorFarah, Angie
dc.contributor.authorMehio-Sibai, Abla Mehio
dc.contributor.departmentHealth Management and Policy (HMPD)
dc.contributor.departmentRefugee Research and Policy Program
dc.contributor.departmentEpidemiology and Population Health (EPHD)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.facultyIssam Fares Institute for Public Policy and International Affairs (IFI)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:35:36Z
dc.date.available2025-01-24T11:35:36Z
dc.date.issued2018
dc.description.abstractBackground Global mortality rates resulting from non-communicable diseases (NCDs) are reaching alarming levels, especially in low- and middle-income countries, imposing a considerable burden on individuals and health systems as a whole. This scoping review aims at synthesizing the existing literature evaluating the cost associated with the management and treatment of major NCDs across all Arab countries; at evaluating the quality of these studies; and at identifying the gap in existing literature. Methods A systematic search was conducted using Medline electronic database to retrieve articles evaluating costs associated with management of NCDs in Arab countries, published in English between January 2000 and April 2016. 55 studies met the eligibility criteria and were independently screened by two reviewers who extracted/calculated the following information: country, theme (management of NCD, treatment/medication, or procedure), study design, setting, population/sample size, publication year, year for cost data cost conversion (US$), costing approach, costing perspective, type of costs, source of information and quality evaluation using the Newcastle- Ottawa Scale (NOS). Results The reviewed articles covered 16 countries in the Arab region. Most of the studies were observational with a retrospective or prospective design, with a relatively low to very low quality score. Our synthesis revealed that NCDs' management costs in the Arab region are high; however, there is a large variation in the methods used to quantify the costs of NCDs in these countries, making it difficult to conduct any type of comparisons. Conclusions The findings revealed that data on the direct costs of NCDs remains limited by the paucity of this type of evidence and the generally low quality of studies published in this area. There is a need for future studies, of improved and harmonized methodology, as such evidence is key for decision- makers and directs health care planning. © 2018, Journal of Health Global.
dc.identifier.doihttps://doi.org/10.7189/jogh.08.020410
dc.identifier.eid2-s2.0-85058237526
dc.identifier.pmid30546867
dc.identifier.urihttp://hdl.handle.net/10938/28389
dc.language.isoen
dc.publisherUniversity of Edinburgh
dc.relation.ispartofJournal of Global Health
dc.sourceScopus
dc.subjectAfrica, northern
dc.subjectArabs
dc.subjectCost of illness
dc.subjectHumans
dc.subjectMiddle east
dc.subjectNoncommunicable diseases
dc.subjectRandomized controlled trials as topic
dc.subjectAfrica
dc.subjectArab
dc.subjectEconomics
dc.subjectHuman
dc.subjectNon communicable disease
dc.subjectRandomized controlled trial (topic)
dc.titleCosts associated with management of non-communicable diseases in the Arab Region: A scoping review
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-4354.pdf
Size:
764.49 KB
Format:
Adobe Portable Document Format